Kabra Drugs LimitedBSE: KABRADG

Kabra Drugs Limited Press Release Oct 09 2025

· Issued by Kabra Drugs Limited via BSE India

Filed with BSE · · 5 pages · English

With reference to the captioned subject and pursuant to the provisions of Regulation 30 and other applicable regulations of the Listing Regulations, please be informed that based on the recommendation of the Nomination and Remuneration Committee and Audit Committee of the Company, the Board of Directors at their meeting held today, i.e., 08th October 2025 have considered and approved taken note of

Kabra Drugs Limited on 6ix

Earlier from Kabra Drugs

Later from Kabra Drugs

All Kabra Drugs news releases